Janssen’s Stelara Wins FDA Approval for Ulcerative Colitis
It's already approved for UC in the EU, so add the USA to the list of countries that can easily get prescribed it. Another option out there to try, and more easily since it is no-longer off-label.
In the Induction study, 19% of patients receiving Stelara achieved clinical remission in 8 weeks. Janssen also noted that Stelara provided rapid relief of symptoms as 58 percent of patients experienced a clinical response at Week 8.
In the maintenance study, 45% of patients who received Stelara remained in remission after one year. Stelara also helped patients achieve clinical remission without the use of corticosteroids, the company noted. At the end of the first year, 43% of patients treated with Stelara were in clinical remission and not receiving steroids, Janssen said.https://www.biospace.com/article/janssen-s-stelara-wins-fda-approval-after-uc-patients-achieve-clinical-remission-in-study/